Literature DB >> 19899008

The importance of tumor volume in the prognosis of patients with glioblastoma: comparison of computerized volumetry and geometric models.

Georgios Iliadis1, Panagiotis Selviaridis, Anna Kalogera-Fountzila, Anna Fragkoulidi, Dimos Baltas, Nikolaos Tselis, Athanasios Chatzisotiriou, Despina Misailidou, Nikolaos Zamboglou, George Fountzilas.   

Abstract

BACKGROUND AND
PURPOSE: The importance of tumor volume as a prognostic factor in high-grade gliomas is highly controversial and there are numerous methods estimating this parameter. In this study, a computer-based application was used in order to assess tumor volume from hard copies and a survival analysis was conducted in order to evaluate the prognostic significance of preoperative volumetric data in patients harboring glioblastomas. PATIENTS AND METHODS: 50 patients suffering from glioblastoma were analyzed retrospectively. Tumor volume was determined by the various geometric models as well as by an own specialized software (Volumio). Age, performance status, type of excision, and tumor location were also included in the multivariate analysis.
RESULTS: The spheroid and rectangular models overestimated tumor volume, while the ellipsoid model offered the best approximation. Volume failed to attain any statistical significance in prognosis, while age and performance status confirmed their importance in progression-free and overall survival of patients.
CONCLUSION: Geometric models provide a rough approximation of tumor volume and should not be used, as accurate determination of size is of paramount importance in order to draw safe conclusions in oncology. Although the significance of volumetry was not disclosed, further studies are definitely required.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19899008     DOI: 10.1007/s00066-009-2015-7

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  24 in total

1.  VOLUMESERIES: a software tool for target volume follow-up studies with computerized tomography and magnetic resonance imaging. Technical note.

Authors:  S G Scheib; S Gianolini; D Haller; G N Wellis; J Siegfried
Journal:  J Neurosurg       Date:  2000-12       Impact factor: 5.115

2.  Prognostic significance of preoperative MRI scans in glioblastoma multiforme.

Authors:  M A Hammoud; R Sawaya; W Shi; P F Thall; N E Leeds
Journal:  J Neurooncol       Date:  1996-01       Impact factor: 4.130

3.  Measurement of tumor resection volumes from computerized images. Technical note.

Authors:  D H Duong; R C Rostomily; D R Haynor; G E Keles; M S Berger
Journal:  J Neurosurg       Date:  1992-07       Impact factor: 5.115

4.  Microcomputer-based technique for 3-D reconstruction and volume measurement of computer tomographic images. Part 1: Phantom studies.

Authors:  R E Albright; E K Fram
Journal:  Invest Radiol       Date:  1988-12       Impact factor: 6.016

5.  Preoperative anaplastic glioma tumor volume effects on patient survival.

Authors:  D Xue; R E Albright
Journal:  J Surg Oncol       Date:  1999-12       Impact factor: 3.454

6.  The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere.

Authors:  G E Keles; B Anderson; M S Berger
Journal:  Surg Neurol       Date:  1999-10

Review 7.  Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?

Authors:  Carsten Nieder; Nicolaus Andratschke; Nicole Wiedenmann; Raymonde Busch; Anca L Grosu; Michael Molls
Journal:  Strahlenther Onkol       Date:  2004-07       Impact factor: 3.621

8.  Hypofractionated stereotactic reirradiation of recurrent glioblastomas : a beneficial treatment option after high-dose radiotherapy?

Authors:  Emmanouil Fokas; Ulrich Wacker; Markus W Gross; Martin Henzel; Elitsa Encheva; Rita Engenhart-Cabillic
Journal:  Strahlenther Onkol       Date:  2009-04-16       Impact factor: 3.621

9.  Delineation of target volume for radiotherapy of high-grade gliomas by 99m Tc-MIBI SPECT and MRI fusion.

Authors:  Marco Krengli; Gianfranco Loi; Gianmauro Sacchetti; Irene Manfredda; Giuseppina Gambaro; Marco Brambilla; Alessandro Carriero; Eugenio Inglese
Journal:  Strahlenther Onkol       Date:  2007-12       Impact factor: 3.621

10.  Postoperative radiotherapy of glioblastoma multiforme: analysis and critical assessment of different treatment strategies and predictive factors.

Authors:  Marc D Piroth; Bernd Gagel; Michael Pinkawa; Sven Stanzel; Branka Asadpour; Michael J Eble
Journal:  Strahlenther Onkol       Date:  2007-12       Impact factor: 3.621

View more
  25 in total

1.  18F-FET-PET-based dose painting by numbers with protons.

Authors:  Mark Rickhey; Zdenek Morávek; Christoph Eilles; Oliver Koelbl; Ludwig Bogner
Journal:  Strahlenther Onkol       Date:  2010-05-21       Impact factor: 3.621

2.  Engineering Controlled Peritumoral Inflammation to Constrain Brain Tumor Growth.

Authors:  Tarun Saxena; Johnathan G Lyon; S Balakrishna Pai; Daniel Pare; Jessica Amero; Lohitash Karumbaiah; Sheridan L Carroll; Eric Gaupp; Ravi V Bellamkonda
Journal:  Adv Healthc Mater       Date:  2018-12-11       Impact factor: 9.933

3.  [Prediction of clinical course of glioblastomas by MRI during radiotherapy].

Authors:  Christina Leitzen; Hans H Schild; Birgitta Bungart; Ulrich Herrlinger; Christiana Lütter; Thomas Müdder; Timo Wilhelm-Buchstab; Heinrich Schüller
Journal:  Strahlenther Onkol       Date:  2010-11-29       Impact factor: 3.621

4.  Short-course radiotherapy in elderly patients with glioblastoma: feasibility and efficacy of results from a single centre.

Authors:  L Fariselli; V Pinzi; I Milanesi; A Silvani; M Marchetti; M Farinotti; A Salmaggi
Journal:  Strahlenther Onkol       Date:  2013-04-28       Impact factor: 3.621

5.  Comparison of volumetric methods for tumor measurements on two and three dimensional MRI in adult glioblastoma.

Authors:  Mei-Yun Wang; Jing-Liang Cheng; Yan-Hong Han; Yong-Li Li; She-Wei Dou; Feng-Shan Yan; Da-Peng Shi
Journal:  Neuroradiology       Date:  2010-11-06       Impact factor: 2.804

6.  Response Assessment in Neuro-Oncology criteria, contrast enhancement and perfusion MRI for assessing progression in glioblastoma.

Authors:  Fatima Tensaouti; Jonathan Khalifa; Amélie Lusque; Benjamin Plas; Jean Albert Lotterie; Isabelle Berry; Anne Laprie; Elizabeth Cohen-Jonathan Moyal; Vincent Lubrano
Journal:  Neuroradiology       Date:  2017-08-25       Impact factor: 2.804

7.  Glioblastoma: does the pre-treatment geometry matter? A postcontrast T1 MRI-based study.

Authors:  Julián Pérez-Beteta; Alicia Martínez-González; David Molina; Mariano Amo-Salas; Belén Luque; Elena Arregui; Manuel Calvo; José M Borrás; Carlos López; Marta Claramonte; Juan A Barcia; Lidia Iglesias; Josué Avecillas; David Albillo; Miguel Navarro; José M Villanueva; Juan C Paniagua; Juan Martino; Carlos Velásquez; Beatriz Asenjo; Manuel Benavides; Ismael Herruzo; María Del Carmen Delgado; Ana Del Valle; Anthony Falkov; Philippe Schucht; Estanislao Arana; Luis Pérez-Romasanta; Víctor M Pérez-García
Journal:  Eur Radiol       Date:  2016-06-21       Impact factor: 5.315

8.  Radiochemotherapy with temozolomide for patients with glioblastoma. Prognostic factors and long-term outcome of unselected patients from a single institution.

Authors:  Johanna Gerstein; Kea Franz; Joachim P Steinbach; Volkert Seifert; Claus Rödel; Christian Weiss
Journal:  Strahlenther Onkol       Date:  2011-10-28       Impact factor: 3.621

9.  Endometrial Cancer: Combined MR Volumetry and Diffusion-weighted Imaging for Assessment of Myometrial and Lymphovascular Invasion and Tumor Grade.

Authors:  Stephanie Nougaret; Caroline Reinhold; Shaza S Alsharif; Helen Addley; Jocelyne Arceneau; Nicolas Molinari; Boris Guiu; Evis Sala
Journal:  Radiology       Date:  2015-04-30       Impact factor: 11.105

10.  Prognostic impact of hemoglobin level and other factors in patients with high-grade gliomas treated with postoperative radiochemotherapy and sequential chemotherapy based on temozolomide: a 10-year experience at a single institution.

Authors:  Giampiero Ausili Céfaro; Domenico Genovesi; Annamaria Vinciguerra; Marianna Trignani; Maria Taraborrelli; Antonietta Augurio; Roberto Buonaguidi; Renato J Galzio; Marta Di Nicola
Journal:  Strahlenther Onkol       Date:  2011-11-25       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.